Ikena Oncology (NASDAQ:IKNA – Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Monday, May 12th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter.
Ikena Oncology (NASDAQ:IKNA – Get Free Report) last issued its quarterly earnings data on Tuesday, March 11th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.05. On average, analysts expect Ikena Oncology to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Ikena Oncology Stock Up 2.5 %
Shares of NASDAQ IKNA opened at $1.25 on Monday. The company has a market cap of $60.32 million, a price-to-earnings ratio of -1.02 and a beta of 0.48. Ikena Oncology has a 12-month low of $0.97 and a 12-month high of $1.94. The firm’s 50-day simple moving average is $1.25 and its 200 day simple moving average is $1.48.
Ikena Oncology Company Profile
Ikena Oncology, Inc operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States. Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway.
Recommended Stories
- Five stocks we like better than Ikena Oncology
- What is a SEC Filing?
- 3 Reasons Tesla Should Be a $300 Stock by June
- What is diluted earnings per share (Diluted EPS)?
- Warning or Opportunity After Super Micro Computer’s Earnings
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?
Receive News & Ratings for Ikena Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ikena Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
